We are live on ! Find out more
APYX icon

Apyx Medical

21 hedge funds and large institutions have $4.17M invested in Apyx Medical in 2014 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

5% more funds holding

Funds holding: 20 → 21 (+1)

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

0.17% less ownership

Funds ownership: 6.57% → 6.4% (-0.17%)

27% less capital inflows, than outflows

Capital inflows: $266K | Capital outflows: $363K

Holders
21
Holders Change
+1
Holders Change %
+5%
% of All Funds
0.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

APYX Hedge Fund Activity: Q4 2014 in Review

21 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q4 2014, worth a combined $4.17M — down 11% from $4.7M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new APYX positions and 1 closed out — a net gain of 2 holders — while 4 added to existing stakes and 4 trimmed.

The largest buyer was Northern Trust, adding an estimated $141K. The largest seller was Millennium Management, cutting an estimated $253K.

  • 21 institutional investors held Apyx Medical (APYX) as of Q4 2014, up from 20 in Q3 2014.
  • Funds reported $4.17M of Apyx Medical stock for Q4 2014, down 11% quarter-over-quarter.
  • 3 funds opened new Apyx Medical positions in Q4 2014 and 1 closed out, a net change of +2 holders.
  • The largest Apyx Medical buyer in Q4 2014 was Northern Trust, an estimated $141K added.
  • The largest Apyx Medical seller in Q4 2014 was Millennium Management, an estimated $253K sold.

Based on aggregated 13F filings for Q4 2014.